Last updated 2026-06-18
- Raised $7.2M funding round, Dec 2018
- Raised $2.5M grant led by European Commission, May 2022
- Raised $4M funding round led by Guangzhou Sino-Israel Biotech Investment Fund (GIBF), Aug 2021
Total raised
$18.8M
Last: Grant 2022-05
Stage
Series B
Founded
2015
Headcount
20
HQ
Ra'anana, Israel
Sector
Health Tech & Life Sciences
About
CorNeat Vision is a medical device company developing and marketing novel, permanent and tissue-integrating implants. Our platform material technology, CorNeat EverMatrix™, overcomes the main issue with implants and implantables – the foreign body response they trigger.
The EverMatrix™ seamlessly and permanently embeds with live tissue without triggering an inflammatory response. Its durability and flexibility, coupled with its bio-integration capabilities, mark a new era of implants.
The EverMatrix™ is set to displace harvested and processed human and animal tissues, including scaffolds and extra cellular matrices, used in a variety of surgical procedures across diversified fields of medicine.
Funding history · 7 rounds · $18.8M total
2022-05
Grant
$2.5M
2021-08
2020-05
$3.4M
2018-12
$7.2M
2018-04
2017-11
Grant
$15K
2017-11
$1.4M
Q&A
- What is CorNeat Vision's primary focus?
- CorNeat Vision is a medical device company that develops and markets novel, permanent, and tissue-integrating implants. Their core technology, CorNeat EverMatrix™, is designed to overcome the foreign body response typically triggered by implants.
- When was CorNeat Vision founded?
- CorNeat Vision was founded in December 2015.
- How many employees does CorNeat Vision have?
- CorNeat Vision has 11-50 employees.
- What is CorNeat Vision's total funding to date?
- CorNeat Vision has raised a total of $18,765,000 across multiple funding rounds.
- When was CorNeat Vision's most recent funding round and who were the lead investors?
- CorNeat Vision's most recent funding was a grant of $2,500,000 from the European Commission in May 2022.
- Which investor participated in CorNeat Vision's August 2021 funding round?
- Guangzhou Sino-Israel Biotech Investment Fund (GIBF) participated in CorNeat Vision's $4,000,000 funding round in August 2021.
- Who are the co-founders of CorNeat Vision?
- The co-founders of CorNeat Vision are Gilad Litvin, who serves as Co-founder, Chairman, and Chief Medical Officer, and Almog Aley-raz, who is Co-founder, CEO, and VP R&D.
- What is CorNeat Vision's primary sector?
- CorNeat Vision's primary sector is Health Tech & Life Sciences.
Team · 2
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
healthcaremedical-devicesvisually-impairedeye-diseases
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | corneat.com/ |
|---|---|
| linkedin.com/company/18006267 | |
| YouTube | youtube.com/channel/UCo1Ma47GaQ5zecSC98a9vbw |
Identifiers & details
| Founded | 2015-12 |
|---|---|
| Employees (exact) | 20 |
Radar intelligence
Patents
| EPO | 8 |
|---|
Web history (Wayback)
| Domain | corneat.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|